AccessibilityHelpAbout Us
SSY Group logo

SSY Group(OTC) LJUIF

Market Cap$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-19%
5 Year-13%
1 Year-41%
1 Month+1%
$0.39
+0.00%
+0.00Today
SSY Group last closing stock price
MetricPriceDate
Last closeUSD 0.402026-06-30
SSY Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.402026-06-02
1 month+0.96%USD 0.392026-03-31
3 month+0.96%USD 0.392026-03-31
Year to date+0.96%USD 0.392025-12-23
1 year-40.95%USD 0.672025-06-23
3 year-36.13%USD 0.622023-05-01
5 year-12.7%USD 0.452021-05-03
Since inception-19.49%USD 0.502015-04-22

SSY Group Financials at a Glance

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$8.96B

Net Income (TTM)

HK$1.17B

EPS (TTM)

$0.02

P/E Ratio

18.05

Dividend

$0.01

Beta (Volatility)

-0.02 (Low)

Price

$0.39

Volume

7

Open

$0.39

Previous Close

$0.39

Daily Range

$0.39 - $0.39

52-Week Range

$0.39 - $0.40

Estimated Earnings Date

Mar 26, 2027

LJUIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SSY Group

SSY Group Limited is an investment holding company primarily engaged in the research, development, manufacturing, and distribution of a diverse range of pharmaceutical products. The company serves hospitals and distributors across China and international markets, offering a wide array of intravenous solutions, injections, and traditional medicines.

Products and Services
  • Intravenous infusion solutions in various packaging formats
  • Ampoules, small volume injections, and oral preparations
  • Pharmaceutical technology research and logistics support
Growth Outlook
  • Revenue increased to HKD 2.36 billion in Q2 2026, up from HKD 2.02 billion in Q4 2025
  • Net income rose to HKD 320 million in Q2 2026, reflecting strong operational efficiency
  • Continued expansion into international markets enhances growth potential
Financial Highlights
  • Trailing twelve-month revenue of HKD 9.1 billion, indicating robust sales performance
  • Net profit margin of 11.59% demonstrates effective cost management
  • Dividend yield of 2.97% offers attractive returns to shareholders
SSY Group Limited operates in the healthcare sector, focusing on pharmaceuticals, which positions the company well within a growing industry. The recent financial performance highlights a significant upward trend in revenue and net income, showcasing the company's ability to capitalize on market opportunities. The diverse product portfolio, including both traditional and innovative pharmaceutical solutions, supports a strong competitive edge. With a solid dividend yield, SSY Group Limited presents an appealing option for investors seeking exposure to the pharmaceutical industry. The company's strategic initiatives and market expansion efforts are expected to drive future growth, making it a noteworthy consideration for potential investors.
AI Generated • Aug 28, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,500

CEO

Ji Guang Qu

Website

www.ssygroup.com.hk

Headquarters

Hong Kong, HK

LJUIF Financials

Key Financial Metrics (TTM)

Gross Margin

40.03%

Operating Margin

14.79%

Net Income Margin

11.59%

Return on Equity

6.72%

Return on Capital

5.16%

Return on Assets

3.77%

Earnings Yield

5.54%

Dividend Yield

2.53%

Payout Ratio

28.91%

Stock Overview

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.95B

Volume

7

Avg. Volume

0.111

Financials (TTM)

Gross Profit

HK$3.66B

Operating Income

HK$1.39B

EBITDA

HK$2.29B

Operating Cash Flow

HK$773.81M

Capital Expenditure

-HK$215.24M

Free Cash Flow

HK$558.57M

Cash & ST Invst.

HK$1.97B

Total Debt

HK$4.05B

SSY Group Performance Analysis

SSY Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 821,663,22919.2%
20232023-12-31HKD 825,527,7230.5%
20242024-12-31HKD 739,879,496-10.4%
20252025-12-31HKD 534,305,242-27.8%
SSY Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-27.1%
Q22025-06-30-11.8%
Q42025-12-31-6.0%
Q22026-06-3017.0%
SSY Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD 0.0544.1%
20232023-12-31HKD 0.0617.7%
20242024-12-31HKD 0.05-18.8%
20252025-12-31HKD 0.02-55.1%
SSY Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-44.9%
Q22025-06-30-24.1%
Q42025-12-31-34.5%
Q22026-06-3074.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

HK$2.36B

-29.3%

Gross Profit

HK$911.84M

-50.5%

Gross Margin

38.64%

N/A

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$215.99K

N/A

Employees

5,500

N/A

Net Income

HK$320.24M

-53.3%

EBITDA

HK$618.39M

-43.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

HK$1.97B

+22.8%

Total Debt

HK$4.05B

+12.1%

Accounts Receivable

HK$1.81B

-18.5%

Inventory

HK$1.24B

+8.5%

Long Term Debt

HK$2.19B

-19.3%

Short Term Debt

HK$1.86B

+107.4%

Return on Assets

3.77%

N/A

Return on Invested Capital

6.08%

N/A

Free Cash Flow

HK$0.00

-100.0%

Operating Cash Flow

HK$0.00

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVOTFEvotec SE
$6.69+0.00%
NPPNYNippon Shinyaku Co., Ltd.
$5.75+0.00%
GNMLFGenomma Lab Internacional, S.A.B. de C.V.
$0.77-0.81%
TCNNFTrulieve Cannabis Corp.
$12.05+2.36%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$210.96-3.36%
FTFTFuture FinTech Group
$8.04+179.17%
NOKNokia
$9.65-13.30%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$101.13-16.98%

Questions About LJUIF

What is the current price of SSY Group?

SSY Group is trading at $0.39 per share.

What is the 52-week range for SSY Group?

Over the past 52 weeks, SSY Group has traded between $0.39 and $0.40.

How much debt does SSY Group have?

As of the most recent reporting period, SSY Group reported total debt of HK$515.79M.

How much cash does SSY Group have on hand?

SSY Group reported HK$219.93M in cash and cash equivalents in its most recent financial results.

What is SSY Group’s dividend yield?

SSY Group currently has a dividend yield of 2.53%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services